| Literature DB >> 31194029 |
Juliane Hollender1,2, Judith Rothardt1, Dirk Radny1, Martin Loos1, Jannis Epting3, Peter Huggenberger3, Paul Borer1, Heinz Singer1.
Abstract
Riverbank filtration (RBF) is used worldwide to produce high quality drinking water. With river water often contaminated by micropollutants (MPs) from various sources, this study addresses the occurrence and fate of such MPs at three different RBF sites with oxic alluvial sediments and short travel times to the drinking water well down to hours. A broad range of MPs with various physico-chemical properties were analysed with detection limits in the low ng L-1 range using solid phase extraction followed by liquid chromatography coupled to tandem high resolution mass spectrometry. Out of the 526 MPs targeted, a total of 123 different MPs were detected above the limit of quantification at the three different RBF sites. Of the 75-96 MPs detected in each river, 43-59% were attenuated during RBF. The remaining total concentrations of the MPs in the raw drinking water accounted to 0.6-1.6 μgL-1 with only a few compounds exceeding 0.1 μgL-1, an often used threshold value. The attenuation was most pronounced in the first meters of infiltration with a full elimination of 17 compounds at all three sites. However, a mixing with groundwater related to regional groundwater flow complicated the characterisation of natural attenuation potentials along the transects. Additional non-target screening at one site revealed similar trends for further non-target components. Overall, a risk assessment of the target and estimated non-target compound concentrations finally indicated during the sampling period no health risk of the drinking water according to current guidelines. Our results demonstrate that monitoring of contamination sources within a catchment and the affected water quality remains important in such vulnerable systems with partially short residence times.Entities:
Keywords: Drinking water; Groundwater; LC-HRMS/MS; Organic contaminants; Risk assessment; Riverbank filtration
Year: 2018 PMID: 31194029 PMCID: PMC6549901 DOI: 10.1016/j.wroa.2018.100007
Source DB: PubMed Journal: Water Res X ISSN: 2589-9147
Fig. 1A and B) Location of the study sites within Switzerland (A) and in the canton Basle-Landscape (B); Detailed view of transects with the respective wells: C) Birs, D) Ergolz; E) Frenke; black arrows indicate both the local (bank filtration) and the regional groundwater flow direction; blue arrows indicate the flow direction of the rivers. Data source base maps: Esri data/AND Data Solutions, B.V. (subfigures A and B); swisstopo, Swiss Map Raster, Bundesamt für Landestopographie (Art.30 Geo IV): 5704 000 000, reproduced by permission of swisstopo/JA100119 (subfigures C to E). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Characterisation of the sampling from surface water and groundwater along the transects (location see Fig. 1); no travel times are shown for the wells 24.A.8, 24.A.2. (both Birs site), 41.J.1 and 41.A.4 (both Ergolz site) as those wells are also impacted by the regional groundwater flow, that superposes signals from bankfiltration. 1 from experimental data; 2 based on Darcy's law including the water levels measured at the day of sampling; T, temperature; EC, electric conductivity; DOC, dissolved organic carbon.
| Measuring point | Site | Date | T | pH | EC | Redox | O2 | DOC | Mean travel time | Discharge |
|---|---|---|---|---|---|---|---|---|---|---|
| 24 h river sample | Birs | 2.-3.12.2013 | 8.3 | 8.3 | 506 | 250 | 12.1 | 1.6 | 0 | 12.7 |
| 24.J.28 | Birs A | 03.12.2013 | 10.5 | 7.1 | 510 | 203 | 8.5 | 1.1 | 10–141 | – |
| 24.A.8 | Birs A | 03.12.2013 | 13.1 | 7.3 | 519 | 227 | 7.8 | 0.6 | – | |
| 24.J.26 | Birs B | 03.12.2013 | 8.0 | 7.7 | 493 | 241 | 7.2 | 1.4 | 19–211 | – |
| 24.A.2 | Birs B | 03.12.2013 | 11.5 | 7.5 | 483 | 216 | 5.7 | 0.7 | – | – |
| 24 h river sample | Ergolz | 4.-5.12.2013 | 6.5 | 8.4 | 667 | 177 | 12.4 | 1.7 | 0 | 3.0 |
| 35.L.1 | Ergolz | 05.12.2013 | 6.4 | 8.0 | 667 | 166 | 9.5 | 1.5 | 141 | – |
| 35.L.2 | Ergolz | 05.12.2013 | 9.0 | 7.9 | 652 | 120 | 10.2 | 1.4 | 391 | – |
| 41.J.1 | Ergolz | 05.12.2013 | 13.1 | 7.6 | 641 | 124 | 8.0 | 1.4 | >3002 | – |
| 41.A.4 | Ergolz | 05.12.2013 | 11.8 | 7.4 | 705 | 123 | 6.5 | 0.9 | >7002 | – |
| 24 h river sample | Frenke | 4.-5.12.2013 | 6.9 | 8.6 | 627 | 234 | 11.9 | 1.8 | 0 | 0.4 |
| 33.A.2 | Frenke | 05.12.2013 | 11.2 | 7.3 | 637 | 257 | 6.8 | 1.2 | 161 | – |
Fig. 2Overview of the number of detected compounds and the total concentration at the three sites Birs, Ergolz and Frenke sorted according to substance classes, as well as boxplots of the concentrations with median, the first and third quartile, whiskers representing the standard deviations, and outliers. Individual values are provided in Table S7.
Compounds attenuated at all three sites more than 50% (top) or persisted at all three sites less than 50% (bottom) with physico-chemical properties and maximum concentration (max. conc.) in the three extraction wells. a, anionic; n, neutral; c, cationic; z, zwitterionic; Pharm, pharmaceutical; Met, metabolite.
| CAS | Compound class | log Kow | Speciation at pH 7 | pKa | Max. conc. extraction wells [μg L−1] | |
|---|---|---|---|---|---|---|
| 4-Acetamidoantipyrin | 83-15-8 | Pharm Met | 0.3 | n | 12.5 | <LOQ |
| Atenolol | 29122-68-7 | Beta blocker | 0.16 | c | 9.7 | <LOQ |
| Bezafibrat | 41859-67-0 | Lipid lowering | 4.25 | a | 3.8 | 0.002 |
| Caffeine | 58-08-2 | Stimulant | −0.07 | n | 0.9 | 0.076 |
| Clopidogrel carboxylic acid | 144457-28-3 | Pharm Met | 1.51 | z | 7.9 | <LOQ |
| Diclofenac | 15307-86-5 | Anti-inflammatory | 4.02 | a | 4.0 | <LOQ |
| Etodolac | 41340-25-4 | Anti-inflammatory | 3.93 | a | 4.7 | <LOQ |
| Flufenamic acid | 530-78-9 | Anti-inflammatory | 5.25 | a | 3.9 | <LOQ |
| Irbesartan | 138402-11-6 | Antihypertensive | 5.31 | a | 4.1 | <LOQ |
| Metformine | 657-24-9 | Antidiabetic | −2.64 | c | 10.3 | <LOQ |
| Metoprolol | 37350-58-6 | Betablocker | 1.88 | c | 9.7 | <LOQ |
| Naproxen | 22204-53-1 | Anti-inflammatory | 3.18 | a | 4.2 | <LOQ |
| Saccharine | 81-07-2 | Sweetener | 0.91 | a | 2.8 | 0.008 |
| Sitagliptin | 486460-32-6 | Antidiabetic | 1.39 | c | 8.8 | <LOQ |
| Trimethoprim | 738-70-5 | Antibiotic | 0.73 | c | 7.2 | 0.003 |
| Valsartan | 137862-53-4 | Antihypertensive | 3.65 | a | 4.4 | <LOQ |
| Valsartanic acid | 164265-78-5 | Pharm Met | 1.83 | a | 4.0 | <LOQ |
| Acesulfame | 55589-62-3 | Sweetener | −1.33 | a | 3.0 | 1.00 |
| Atrazine-2-Hydroxy | 2163-68-0 | Herbicide Met | 2.09 | n | 3.0 | 0.010 |
| Candesartan | 139481-59-7 | Antihypertensive | 4.79 | a | 3.9 | 0.018 |
| Carbamazepine | 298-46-4 | Anticonvulsant | 2.45 | n | 16.0 | 0.041 |
| Chloridazon-desphenyl | 6339-19-1 | Herbicide Met | −0.41 | z | 6.6 | 0.020 |
| Chloridazon-methyl-desphenyl | 17254-80-7 | Herbicide Met | −1.37 | n | 15.8 | 0.016 |
| 2,6-Dichlorobenzamide | 2008-58-4 | Herbicide | 0.9 | n | 12.1 | 0.003 |
| Hydrochlorothiazide | 58-93-5 | Antihypertensive | −0.07 | n | 9.1 | 0.038 |
| Lamotrigine | 84057-84-1 | Anticonvulsant | 2.57 | n | 5.9 | 0.044 |
| 4/5-Methyl-benzotriazole | 136-85-6 | Industrial | 1.71 | n | 8.9 | 0.081 |
| Metolachlor-ESA | 171118-09-5 | Herbicide Met | 1.69 | a | 13.7 | 0.007 |
| Sucralose | 56038-13-2 | Sweetener | −1 | n | 11.9 | 0.120 |
| Sulfamethoxazole | 723-46-6 | Antibiotic | 0.89 | n | 2.0 | 0.020 |
US EPA, 2012.
Parent compound no longer registered in Switzerland.
Fig. 3Venn diagram of non-target profile component numbers occurring at the Ergolz sampling sites. Only blind-filtered non-target profiles occurring in all three replicates are included in the diagram. Blue, 24 h-composite sample Ergolz; white, observation well close to the Ergolz (water age. 14 and 39 h, Table 1); brown, drinking water well (water age > 700 h). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Fig. 4A) Cumulative intensity distribution of the four sampling sites at Ergolz over the total of 7465 component profiles shown in Fig. 3, using the maximum peak intensity per replicate and site for each profile. B) Cumulative distribution of estimated concentrations for the component profiles at the drinking water extraction site. The three quantiles refer to the concentration estimates of each non-target profile formed over the different calibration models utilized for the quantification estimation.